Quick Answer
Bone Biologics Corp reported Total Assets of $5.80 million for fiscal year 2025.
Bone Biologics Corp Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $5.80M | +50.1% |
| 2024 | $3.86M | +3.3% |
| 2023 | $3.74M | -56.0% |
| 2022 | $8.50M | +27.3% |
| 2021 | $6.68M | — |
| 2020 | $0.00 | -100.0% |
| 2019 | $30.8K | -97.0% |
| 2018 | $1.04M | +30.8% |
| 2017 | $795.7K | -52.3% |
| 2017 | $1.67M | +92.1% |
| 2017 | $868.4K | -48.8% |
| 2017 | $1.70M | +141.9% |
| 2016 | $701.1K | -9.1% |
| 2016 | $771.4K | -66.9% |
| 2016 | $2.33M | -46.0% |
| 2016 | $4.32M | +179.4% |
| 2015 | $1.55M | -59.5% |
| 2014 | $3.82M | +4277.1% |
| 2013 | $87.3K | +22875.0% |
| 2013 | $380.00 | -24.0% |
| 2012 | $500.00 | — |
| 2011 | $0.00 | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $6.35M | +56.2% | -9.3% |
| June 30, 2025 | $7.00M | +119.3% | +121.4% |
| March 31, 2025 | $3.16M | -17.6% | -18.1% |
| December 31, 2024 | $3.86M | +3.3% | -5.0% |
| September 30, 2024 | $4.07M | -18.3% | +27.3% |
| June 30, 2024 | $3.19M | -58.1% | -16.8% |
| March 31, 2024 | $3.84M | -43.4% | +2.7% |
| December 31, 2023 | $3.74M | -56.0% | -24.9% |
- Bone Biologics Corp showed an increase of +50.1% in Total Assets compared to the prior fiscal year.
- The most recent figure is from Bone Biologics Corp’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 2, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: